Niagen Bioscience (NAGE) Debt Ratio (2016 - 2018)

Niagen Bioscience's (NAGE) quarterly Debt Ratio came in at 0.0 in Q4 2018, down 34.36% year-on-year from 0.0 in Q4 2017, and down 34.36% on a QoQ basis from 0.0 in Q4 2017.

Niagen Bioscience (NAGE) Debt Ratio (2016 - 2018) Analysis & Trends

Niagen Bioscience (NAGE) has 3 years of Debt Ratio data on file, last reported at 0.0 in Q4 2018.

  • On a quarterly basis, Debt Ratio fell 34.36% year-over-year to 0.0 in Q4 2018; TTM through Dec 2018 was 0.0, a 34.36% decrease from a year earlier, with the FY2018 full-year figure at 0.0, down 34.36% from the prior year.
  • Debt Ratio for Q4 2018 stood at 0.0, down from 0.0 in the prior quarter.
  • Over the last five years, Debt Ratio for NAGE reached as high as 0.26 in Q1 2016 and fell as low as 0.0 in Q4 2018.
  • Historically, Debt Ratio has averaged 0.07 across 3 years, with a median of 0.01 in 2016.
  • Across the five-year window, Debt Ratio slumped 93.3% in 2016 and plunged 34.36% in 2018, its largest moves.
  • Year by year, Debt Ratio stood at 0.02 in 2016, then sank by 71.62% to 0.0 in 2017, then plunged by 34.36% to 0.0 in 2018.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q4 2018, 0.0 in Q4 2017, and 0.02 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Niagen Bioscience 253.47 Mn 186.92 Mn 19.98 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 0.00
Dec 30, 2017 0.00
Dec 31, 2016 0.02
Jan 2, 2016 0.26